341 related articles for article (PubMed ID: 25893287)
1. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
2. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
3. K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.
Pearson HB; Phesse TJ; Clarke AR
Cancer Res; 2009 Jan; 69(1):94-101. PubMed ID: 19117991
[TBL] [Abstract][Full Text] [Related]
4. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
He Y; Mi J; Olson A; Aldahl J; Hooker E; Yu EJ; Le V; Lee DH; Kim WK; Robins DM; Geradts J; Sun Z
Oncogene; 2020 Apr; 39(16):3276-3291. PubMed ID: 32089544
[TBL] [Abstract][Full Text] [Related]
7. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate.
Zhu C; Luong R; Zhuo M; Johnson DT; McKenney JK; Cunha GR; Sun Z
J Biol Chem; 2011 Sep; 286(38):33478-88. PubMed ID: 21795710
[TBL] [Abstract][Full Text] [Related]
8. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
9. Androgen signaling is essential for development of prostate cancer initiated from prostatic basal cells.
He Y; Hooker E; Yu EJ; Cunha GR; Liao L; Xu J; Earl A; Wu H; Gonzalgo ML; Sun Z
Oncogene; 2019 Mar; 38(13):2337-2350. PubMed ID: 30510232
[TBL] [Abstract][Full Text] [Related]
10. Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
Yu X; Wang Y; Jiang M; Bierie B; Roy-Burman P; Shen MM; Taketo MM; Wills M; Matusik RJ
Prostate; 2009 Feb; 69(3):249-62. PubMed ID: 18991257
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate.
Lee DH; Yu EJ; Aldahl J; Yang J; He Y; Hooker E; Le V; Mi J; Olson A; Wu H; Geradts J; Xiao GQ; Gonzalgo ML; Cardiff RD; Sun Z
PLoS One; 2019; 14(1):e0211153. PubMed ID: 30677079
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Apc in the mouse prostate causes prostate carcinoma.
Bruxvoort KJ; Charbonneau HM; Giambernardi TA; Goolsby JC; Qian CN; Zylstra CR; Robinson DR; Roy-Burman P; Shaw AK; Buckner-Berghuis BD; Sigler RE; Resau JH; Sullivan R; Bushman W; Williams BO
Cancer Res; 2007 Mar; 67(6):2490-6. PubMed ID: 17363566
[TBL] [Abstract][Full Text] [Related]
14. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
15. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
16. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
19. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.
Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N
Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967
[TBL] [Abstract][Full Text] [Related]
20. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
